快意電梯(002774.SZ)回購註銷6.92萬股限制性股票
格隆匯8月20日丨快意電梯(002774.SZ)公佈,公司於2018年7月10日披露了《關於2018年限制性股票激勵計劃首次授予登記完成的公告》,授予日為2018年6月19日,上市日期為2018年7月11日。
因部分激勵對象因個人原因離職以及個人業績考核為C,公司需對7名人員已獲授但尚未解除限售的合計6.92萬股限制性股票進行回購註銷,回購價格為4.45元/股,此次註銷股份佔註銷前總股本比例為0.0203%。
截至2019年8月20日,上述限制性股票已在中國證券登記結算有限責任公司深圳分公司完成回購註銷手續。此次回購註銷完成後,公司總股本由3.4147億股變更為3.4140億股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.